covid-19
Showing NaN - NaN of 84
COVID-19 Trial in Houston (COVID-19 Group Problem Solving, Control Group-standard of care)
Active, not recruiting
- COVID-19
- COVID-19 Group Problem Solving
- Control Group-standard of care
-
Houston, TexasThe University of Texas Health Science Center at Houston
May 18, 2022
COVID-19 Trial in Worldwide (Losmapimod oral tablet, Placebo oral tablet)
Terminated
- COVID-19
- Losmapimod oral tablet
- Placebo oral tablet
-
Irvine, California
- +15 more
Mar 30, 2022
COVID-19, Coronavirus, Coronavirus Infection Trial in United States (Convalescent Plasma, Saline solution)
Active, not recruiting
- COVID-19
- +2 more
- Convalescent Plasma
- Saline solution
-
New Haven, Connecticut
- +8 more
Mar 30, 2022
COVID-19 Trial in United States (Favipiravir, Standard of Care)
COVID-19 Trial in United States (RBT-9 (90 mg), 0.9% sodium chloride (normal saline))
Terminated
- COVID-19
- RBT-9 (90 mg)
- 0.9% sodium chloride (normal saline)
-
New Smyrna Beach, Florida
- +4 more
Feb 17, 2022
COVID-19 Pulmonary Complications, COVID-19 Trial in United States (Zanubrutinib, Supportive Care, Placebo)
Completed
- COVID-19 Pulmonary Complications
- COVID-19
- Zanubrutinib
- +2 more
-
Scottsdale, Arizona
- +17 more
Feb 25, 2022
SARS-CoV-2 Infection, COVID-19 Trial in United States (BNT162b2, BNT162b2.B.1.351)
Completed
- SARS-CoV-2 Infection
- COVID-19
- BNT162b2
- BNT162b2.B.1.351
-
Oakland, California
- +16 more
Feb 17, 2022
COVID-19, SARS-CoV-2 Trial in United States (Sargramostim, Standard of care)
Completed
- COVID-19
- SARS-CoV-2
- Sargramostim
- Standard of care
-
Fullerton, California
- +10 more
Feb 16, 2022
COVID-19 Trial in United States (Apixaban 2.5 MG, Apixaban 5MG, Aspirin)
Terminated
- COVID-19
- Apixaban 2.5 MG
- +3 more
-
Los Angeles, California
- +70 more
Feb 15, 2022
COVID-19 Trial in Houston (HB-adMSC, Placebo)
Terminated
- COVID-19
- HB-adMSC
- Placebo
-
Houston, Texas
- +1 more
Jan 24, 2022
COVID-19 Trial in United States (Camostat Mesilate, Placebo)
Completed
- COVID-19
- Camostat Mesilate
- Placebo
-
Palm Springs, California
- +20 more
Jan 13, 2022
COVID-19 Trial in Spain, United States (BI 767551 intravenous, BI 767551 inhaled, Placebo intravenous)
Terminated
- COVID-19
- BI 767551 intravenous
- +3 more
-
Miami Springs, Florida
- +4 more
Nov 18, 2021
Covid-19 Trial in United States (Abivertinib, Standard of Care)
Completed
- Covid-19
- Abivertinib
- Standard of Care
-
Washington, District of Columbia
- +5 more
Nov 1, 2021
COVID-19 Trial in Spain, United States (Self-prone position recommendation, Usual care)
Completed
- COVID-19
- Self-prone position recommendation
- Usual care
-
Long Beach, California
- +12 more
Oct 25, 2021
SARS-CoV-2/COVID-19 Prevalence Study
Completed
- COVID-19
-
Aurora, Colorado
- +14 more
Sep 29, 2021